defective drug law firm baltimore, product liability attorneys maryland, birth injuries

Popular Morning Sickness Drug Zofran Linked to Serious Birth Injuries

March 18th, 2015

Nausea and vomiting are common in early pregnancy and may actually serve to protect the developing fetus. Most symptoms of so-called “morning sickness” can be managed conservatively without resorting to medication. This is important because between the years of 1980 and 2014, there were no morning sickness drugs on the market that had passed the Food and Drug Administration’s (FDA) approval process. This approval process is where drug companies must show testing that establishes both the safety and efficacy of their medication. Several previous anti-nausea drugs given to pregnant women caused severe birth defects and were taken off the market as a result.

However, when a drug is approved by the FDA for one use, doctors are free to prescribe it “off-label” for other medical conditions. GlaxoSmithKline (“GSK”) took its popular cancer drug Zofran and marketed it “off-label” for use in pregnant women to help alleviate morning sickness. In spite of the fact that drug companies are prohibited from promoting sales of their drugs for uses which were not safety tested and FDA approved, GSK marketed Zofran “off-label” to obstetricians who often prescribed it to pregnant women. Over 110,000 Zofran prescriptions are estimated to have been written to expecting mothers in 2013 alone. Doctors were not told by the drug company about the risks associated with Zofran.

It is clear that GSK put sales ahead of the safety of their customers.

Studies show that using Zofran during the first 10 weeks of pregnancy doubles a woman’s risk for having a baby with a cleft palate or heart defects. Further research on the potential harm Zofran caused to unborn children is ongoing, but both the FDA and the American College of Obstetricians and Gynecologists have cautioned against the use of Zofran during pregnancy.

The United States brought suit against GSK related to its “off-label” promotion, including the off-label promotion of Zofran for use in treating morning sickness. In 2012, GSK agreed to pay more than a billion dollars to settle the government’s claims.  Now, women across the country are bringing suit against GSK on behalf of their babies who were born with cleft palates, limb deformities, and heart defects.

We at the Yost Legal Group are experienced pharmaceutical and birth injury attorneys.  If you or a loved one has been seriously injured as a result of using Zofran during pregnancy, you may be entitled to compensation.  Call 1-800-YOST-LAW (967-8529) for help.

There is no attorney’s fee or expense unless you recover.

The Yost Legal Group – Experienced Attorneys Dedicated to Protecting Your Rights

Complications from Fetal Macrosomia Baby after birth

A baby born weighing more than 8 pounds 13 ounces (or 4,000 grams) weighs significantly more than the average baby, and so meets the definition for macrosomia, or “big baby syndrome”, which carries with it the risk of injury during delivery.   If the baby’s birthweight is even greater – 9 pounds 15 ounces (or 4,500 grams) and above – the chance of injury during birth is even higher. Roughly 10% of all babies born within…

Read More »

Seizure Activity in Newborns – Hypoxia

According to the Florida Neonatal Neurological Network about 20 out of every 1,000 full term births will be affected by a lack of oxygen to the brain (hypoxia) during labor and delivery.  Babies who are born prematurely are at even greater risk, because their lungs are not fully developed and they are unable to fully manage breathing on their own. Hypoxia is the most frequent cause of seizure activity in newborns and can cause additional…

Read More »

Periventricular Leukomalacia in Newborns

Periventricular leukomalacia (PVL) is an injury to the brain which occurs when tissue deep in the baby’s brain, called the white matter, dies away or is damaged.   If a baby’s brain does not receive enough oxygen during labor and delivery, the brain cells in the baby’s white matter can die or be damaged.  The patches of damaged or dying brain cells which lead to a diagnosis of PVL can be seen on brain imaging studies,…

Read More »

Birth Injury Due To Placental Abruption

The placenta is an organ that develops inside a woman’s uterus during pregnancy. Once a baby is conceived, the placenta forms to supply oxygen and nutrients to the baby, as well as remove waste products from the baby’s blood. The placenta attaches to the uterine wall, and the baby’s umbilical cord arises from it. In some cases, however, the placenta can separate from the uterine wall, causing the baby to stop receiving an adequate supply…

Read More »